Should clindamycin be used as treatment of patients with infections caused by erythromycin-resistant staphylococci?

J Antimicrob Chemother. 1999 Oct;44(4):581-2. doi: 10.1093/jac/44.4.581.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Clindamycin / therapeutic use*
  • Drug Resistance, Microbial
  • Erythromycin / therapeutic use*
  • Humans
  • Lincosamides
  • Macrolides*
  • Microbial Sensitivity Tests
  • Staphylococcal Infections / drug therapy*
  • Virginiamycin / pharmacology

Substances

  • Anti-Bacterial Agents
  • Lincosamides
  • Macrolides
  • Virginiamycin
  • Clindamycin
  • Erythromycin